| Bioactivity | Inezetamab is a bispecific anti-CD40 and anti-MSLN IgG1 monoclonal antibody[1]. |
| Target | CD40, MSLN |
| Name | Inezetamab |
| CAS | 2568264-76-4 |
| Storage | Please store the product under the recommended conditions in the Certificate of Analysis. |
| Reference | [1]. WHO Drug Information, Vol. 36, No. 3, 2022. Geneva: World Health Organization; 2022. Licence: CC BY-NC-SA 3.0 IGO. |